|
|
|
Article Cited by others ORIGINAL ARTICLE
FISH for HER-2/neu in breast cancer: Standardization makes the difference!
Gokhale Sumita, Gatalica Zoran, Mohammad Amin, Rampy A I, Velagaleti Gopalrao V N
Year : 2004| Volume: 41| Issue : 4 | Page no: 152-158 | This article has been cited by | | 1 |
Copy Number Gains in 11q13 and 8q34 Are Highly Linked to Prognosis in Cutaneous Malignant Melanoma |
|
| | Gerami, P., Jewell, S.S., Pouryazdanparast, P., Wayne, J.D., Haghighat, Z., Busam, K.J., Rademaker, A., Morrison, L. | | | Journal of Molecular Diagnostics. 2011; 13(3): 352-358 | | | [Pubmed] [Google Scholar] | | | 2 |
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and 18F-labeled affibody molecules |
|
| | Kramer-Marek, G., Kiesewetter, D.O., Capala, J. | | | Journal of Nuclear Medicine. 2009; 50(7): 1131-1139 | | | [Pubmed] [Google Scholar] | | | 3 |
HER2 gene status in primary breast cancers and matched distant metastases |
|
| | Tapia, C., Savic, S., Wagner, U., Schönegg, R., Novotny, H., Grilli, B., Herzog, M., (...), Bubendorf, L. | | | Breast Cancer Research. 2007; 9(3): Ar R31 | | | [Pubmed] [Google Scholar] | | | 4 |
Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer |
|
| | Swellam, M., Arab, L.R.E.E., Bushnak, H.A. | | | IUBMB Life. 2007; 59(6): 394-401 | | | [Pubmed] [Google Scholar] | | | 5 |
Clinical findings and HER-2/neu gene amplification status of breast carcinoma patients |
|
| | Sahin, F.I., Yilmaz, Z., Yaǧmurdur, M.C., Atac, F.B., Ozdemir, B.H., Karakayali, H., Demirhan, B., Haberal, M. | | | Pathology Oncology Research. 2006; 12(4): 211-215 | | | [Pubmed] [Google Scholar] | |
|
|
